Concentration-effect and concentration-toxicity relations with lamotrigine: A prospective study

Epilepsia

Volumn 37, Issue 6, 1996, Pages 534-538

  Kilpatrick, E S ^a   Forrest, G ^a   Brodie, Martin J ^a  

^a WESTERN INFIRMARY   (United Kingdom)

Author keywords

Concentration; Efficacy; Epilepsy; Lamotrigine; Toxicity

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; LAMOTRIGINE; PHENOBARBITAL; PHENYTOIN; VALPROIC ACID; VIGABATRIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONCENTRATION RESPONSE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPLOPIA; DOSE RESPONSE; DRUG EFFICACY; DRUG MONITORING; EPILEPSY; FEMALE; HEADACHE; HEART PALPITATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEIZURE THRESHOLD; VERTIGO;

ADOLESCENT; ADULT; ANTICONVULSANTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG MONITORING; DRUG THERAPY, COMBINATION; EPILEPSY; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAZINES;

EID: 0029941546     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1528-1157.1996.tb00605.x     Document Type: Article

References (16)

1. - channels in rat hippocampai neurones. Pflugers Arch 1995;430:437-40.
2. Leach JP, Brodie MJ. Lamotrigine: clinical use. In: Levy RH, Mattson RH, Meldrum BS, eds. Antiepileptic drugs, 4th ed. New York: Raven Press. 1995:889-95.
3. Brodie MJ, Richens A, Yuen AWC, and the UK Lamotrigine/ Carbamazepine Monotherapy Trial Group. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995;345:476-9.
4. Steiner TJ, Silveira C, Yuen AWC, and the North Thames Lamictal Study Group. Comparison of lamotrigine (Lamictal) and phenytoin in newly diagnosed epilepsy. Epilepsia 1994;35(suppl 7):61.
5. Cohen AF, Land GS, Breimer D, Yuen WC, Winton C, Peck AW. Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans. Clin Pharmacol Ther 1987;42:535-41.
6. Cociglio M, Alric R, Bouvier D. Performance analysis of a reversed-phase liquid chromatographic assay of lamotrigine in plasma using solvent-demixing extraction. J Chromatogr 1991;572:269-76.
7. Fazio A, Artesi C, Russo M, Trio R, Oteri G, Pisani F. A liquid chromatographic assay using a high speed column for determination of lamotrigine, a new antiepileptic drug, in human plasma. Ther Drug Monir 1992;14:509-12.
8. Sailstad JM, Findlay JWA. Immunofluorometric assay for lamotrigine (Lamictal) in human plasma. Ther Drug Monit 1991;13:433-42.
9. Brodie MJ. Lamotrigine. Lancet 1992;339:1397-400
10. Brodie MJ, Feely J. Practical clinical pharmacology. Therapeutic drug monitoring and clinical trials. Br Med J 1988;296:1110-4.
11. Rambeck B, Wolf P. Lamotrigine clinical pharmacokinetics. Clin Pharmacokinet 1993;25:433-43.
12. Betts T, Goodwin G, Withers RM, Yuen AWC. Human safety of lamotrigine. Epilepsia 1991;32(suppl 2):17-21.
13. Brodie MJ. Lamotrigine monotherapy: an overview. Neurology 1996 (in press).
14. Buckley NA, Whyte IM, Dawson AH. Self-poisoning with lamotrigine. Lancet 1993;342;1552-3.
15. Leach JP, Brodie MJ. Novel antiepileptic drugs: an explosion of activity. Seizure 1995;4:5-17.
16. McKee PJW, Brodie MJ. Therapeutic drug monitoring. In: Engel J Jr, Pedley TA. eds. Epilepsy: a comprehensive textbook. New York: Raven Press, 1996.